Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong
Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M. S. Cheng, et al.
Respirology (2021) Vol. 27, Iss. 4, pp. 301-310
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 486-489
Open Access | Times Cited: 354
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
Alejandro Jara, Eduardo A. Undurraga, José R. Zubizarreta, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 6, pp. e798-e806
Open Access | Times Cited: 192
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 178
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 348-357
Open Access | Times Cited: 156
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 142
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
Siew C. Ng, Ye Peng, Lin Zhang, et al.
Gut (2022) Vol. 71, Iss. 6, pp. 1106-1116
Open Access | Times Cited: 141
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
Jing Lian Suah, Masliyana Husin, Peter Seah Keng Tok, et al.
International Journal of Infectious Diseases (2022) Vol. 119, pp. 69-76
Open Access | Times Cited: 68
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 42
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
Lirong Cao, Jingzhi Lou, See Yeung Chan, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1715-1722
Open Access | Times Cited: 39
Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals
Haogao Gu, Ahmed Abdul Quadeer, Pavithra Krishnan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster
Xun Wang, Shujun Jiang, Wentai Ma, et al.
Cell Host & Microbe (2023) Vol. 32, Iss. 1, pp. 25-34.e5
Open Access | Times Cited: 28
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 12
A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac
Chris Ka Pun Mok, Chunke Chen, Karen Yiu, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 7, pp. 844-847
Open Access | Times Cited: 35
Hybrid immunity and strategies for COVID-19 vaccination
David S.C. Hui
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 2-3
Open Access | Times Cited: 35
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022
Samuel M. S. Cheng, Chris Ka Pun Mok, Karl CK Chan, et al.
Eurosurveillance (2022) Vol. 27, Iss. 18
Open Access | Times Cited: 34
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 33
Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19
Wei Zhao, Weixin Chen, Juan Li, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 31
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
Zehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Obesity Surgery (2022) Vol. 32, Iss. 9, pp. 2987-2993
Open Access | Times Cited: 31
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
Lu Lu, Lin‐Lei Chen, Ruiqi Zhang, et al.
EBioMedicine (2022) Vol. 79, pp. 103986-103986
Open Access | Times Cited: 30
SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
Asmaa Hachim, Haogao Gu, Otared Kavian, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
Chris Ka Pun Mok, Chunke Chen, Shilin Zhao, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 6, pp. e418-e430
Open Access | Times Cited: 19
Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review
Yanfei He, Jing Ouyang, Xiao Hu, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 6, pp. 892-918
Open Access | Times Cited: 19
Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS‐CoV‐2: A longitudinal study
Zeynep Ece Kuloğlu, Rojbin El, Gülen Güney-Esken, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2459-2467
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top